By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Converts More Than 500 U.S. Patients To Second Generation Optune Within Four Weeks Of FDA Approval On July 13 8/16/2016 10:08:49 AM
NovoCure To Present At Upcoming Investor Conferences 8/9/2016 11:31:58 AM
NovoCure Reports Second Quarter 2016 Financial Results and Provides Company Update 7/28/2016 11:11:57 AM
NovoCure To Host Research And Development Day On Dec. 12, 2016 7/28/2016 11:09:15 AM
NovoCure Release: National Comprehensive Cancer Network Guidelines Recommend Optune As A Standard Treatment Option For Newly Diagnosed Glioblastoma 7/26/2016 10:06:41 AM
NovoCure Snags FDA Approval for Second Generation Optune System 7/14/2016 7:23:45 AM
NovoCure Announces $75 Million Drawdown Under Its Term Loan Agreement Through Pharmakon Advisors 7/1/2016 9:31:29 AM
NovoCure To Report Second Quarter 2016 Financial Results 6/30/2016 8:58:40 AM
NovoCure To Present At JMP Securities 2016 Life Sciences Conference 6/8/2016 1:09:09 PM
NovoCure Receives IDE Approval To Initiate METIS Trial 5/31/2016 12:48:22 PM